Godrej Consumer’s ₹450-Crore Muuchstac Acquisition Signals New FMCG Playbook
Godrej Consumer acquires men’s grooming brand Muuchstac in a ₹450-crore deal. Founders will continue running operations as GCPL expands into high-margin D2C categories.
Healthcare
FMCG, Healthcare, News, Pharma, Tech
Sun Pharma Secures License Deal
Sun Pharma has resolved its U.S. patent litigation with Incyte Corporation, securing a license to launch LEQSELVI (deuruxolitinib) for severe alopecia areata. This strategic move enables Sun to enter the U.S. dermatology market with a high-impact JAK inhibitor, offering new hope to millions affected by the autoimmune disorder.
FMCG, Healthcare, News, Tech
Religare Enterprises Cleans ₹1,500 Crore Fundraise: Burman Family to Invest ₹750 Crore
Religare Enterprises has approved a ₹1,500 crore fundraise to fuel growth across verticals. The Burman family, promoters of Dabur, will contribute ₹750 crore, signaling long-term commitment and strategic direction.
Market Wrap – July 9
On July 9, 2025, Indian markets faced global headwinds as US tariff hikes targeted pharma and metals, but strong domestic developments in steel, infra, and upcoming IPOs like Anthem Biosciences kept investor sentiment balanced.
Market Wrap – July 8
Indian stock markets ended strong on July 8, 2025, backed by institutional buying, upbeat earnings from key companies like Kotak Bank and M&M, and positive momentum in realty and banking sectors, even as global tariff tensions weighed on sentiment.
Nectar Lifesciences Sells API
Nectar Lifesciences sells its core API, formulation & menthol businesses to Ceph Lifesciences for ₹1,290 Cr. Learn about the deal structure, strategy, and market impact.
Market Wrap – July 7, 2025
Despite global trade friction and sectoral rotation in equities, India Inc continues to post encouraging earnings in healthcare, retail, and banking—setting the tone for a resilient FY26.
Market Wrap – July 4, 2025
The Indian markets ended higher on July 4, 2025, with sectoral buying in Oil & Gas, IT, Pharma, and Banking, while Metals and Auto saw profit booking. Key highlights included Bharat Forge’s new defence arm, strong Q1 updates from Bajaj Finance, Vedanta, and Torrent Pharma’s JB Chemicals stake buy. Regulatory changes in gas tariffs and corporate actions like bonus issues and mutual fund launches also shaped the session. FIIs continued to sell, while DIIs supported the rally. US markets remained closed for Independence Day.
Market Wrap – July 3, 2025
From improving PMI numbers and tariff shifts to retail growth and a buzzing IPO pipeline, India’s economic momentum continues to gain pace despite global uncertainties. Sectors like textiles, retail, pharma, and power are showing strength, while investor focus remains strong on Q1 earnings and global cues.